• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于常规临床实验室中监测西罗莫司和依维莫司的高通量 LC-MS/MS 方法。

High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.

机构信息

Department of Laboratory Medicine, University-Hospital, Padova, Italy.

出版信息

Clin Chem Lab Med. 2011 Jul;49(7):1151-8. doi: 10.1515/CCLM.2011.192. Epub 2011 May 17.

DOI:10.1515/CCLM.2011.192
PMID:21574883
Abstract

BACKGROUND

Immunosuppressant therapeutic drug monitoring (TDM) is an important requirement in post-transplant patient care. In recent years, high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has become a valid alternative to antibody-based immunoassays in TDM due to its high specificity and sensitivity. Furthermore, this technology allows for the simultaneous measurement of several immunosuppressive drugs. The aim of the present study was to establish a straightforward, robust, and high-throughput LC-MS/MS method for the simultaneous determination of sirolimus and everolimus in whole blood in order to replace immunoassays in our routine practice.

METHODS

Five-level blood calibrators were employed for assay development, while three materials at different concentrations were used for internal quality control. The proposed method uses protein precipitation for sample preparation. Analyses were performed using a triple quadrupole LC-MS/MS, with a C18 held at 60°C. Using an appropriate gradient elution profile and SPE on-line, elution times for all compounds analysed were 2.6 min with a total run-time of 3.5 min.

RESULTS

Calibration curves were linear throughout the selected ranges. The intra- and inter-assay CVs (<7%), the limit of quantification (0.2 μg/L) and accuracy were highly satisfactory. On testing the results using the international proficiency testing scheme (UK-NEQAS), the performance of the proposed method was found to be highly reliable.

CONCLUSIONS

The findings made by us indicate that the proposed method is of value, since it is speedy, straightforward, accurate, and applicable to different LC-MS/MS instruments for the routine TDM of organ transplant recipients.

摘要

背景

免疫抑制剂治疗药物监测(TDM)是移植后患者护理的重要要求。近年来,由于其高特异性和灵敏度,高效液相色谱-串联质谱(LC-MS/MS)已成为 TDM 中基于抗体的免疫分析的有效替代方法。此外,该技术允许同时测量几种免疫抑制剂。本研究旨在建立一种简单、稳健、高通量的 LC-MS/MS 方法,用于同时测定全血中的西罗莫司和依维莫司,以替代我们常规实践中的免疫分析。

方法

采用五级血校准品进行方法开发,同时采用三种不同浓度的材料进行内部质量控制。所提出的方法使用蛋白质沉淀进行样品制备。分析采用三重四极杆 LC-MS/MS 进行,C18 在 60°C 下保持。采用适当的梯度洗脱程序和在线 SPE,所有分析物的洗脱时间为 2.6 分钟,总运行时间为 3.5 分钟。

结果

校准曲线在所选范围内呈线性。日内和日间 CV(<7%)、定量限(0.2 μg/L)和准确度均非常令人满意。使用国际能力验证计划(英国-NEQAS)测试结果,发现所提出方法的性能非常可靠。

结论

我们的研究结果表明,所提出的方法具有价值,因为它快速、简单、准确,适用于不同的 LC-MS/MS 仪器,用于器官移植受者的常规 TDM。

相似文献

1
High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.用于常规临床实验室中监测西罗莫司和依维莫司的高通量 LC-MS/MS 方法。
Clin Chem Lab Med. 2011 Jul;49(7):1151-8. doi: 10.1515/CCLM.2011.192. Epub 2011 May 17.
2
Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.用于全血中环孢素、他克莫司、依维莫司和西罗莫司治疗药物监测的稳健、高通量液相色谱-串联质谱法。
Ther Drug Monit. 2009 Feb;31(1):116-25. doi: 10.1097/FTD.0b013e318192304c.
3
A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.一种使用同位素依维莫司内标通过液相色谱-串联质谱法直接测定全血中依维莫司和西罗莫司的方法。
Ther Drug Monit. 2014 Jun;36(3):358-65. doi: 10.1097/FTD.0000000000000006.
4
Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.LC-MS/MS 法进行免疫抑制剂治疗药物监测:通过自动化处理全血样本优化工作流程。
Clin Biochem. 2013 Nov;46(16-17):1723-7. doi: 10.1016/j.clinbiochem.2013.08.013. Epub 2013 Sep 5.
5
Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.LC-MS/MS 在线样品净化法灵敏定量检测西罗莫司和依维莫司
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Apr 15;878(13-14):1007-12. doi: 10.1016/j.jchromb.2010.02.029. Epub 2010 Mar 6.
6
Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.采用液质联用色谱法对依维莫司进行定量分析时,稳定同位素标记物与模拟内标物的比较。
Ther Drug Monit. 2013 Apr;35(2):246-50. doi: 10.1097/FTD.0b013e318283403e.
7
A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood.一种用于测定全血中西罗莫司和依维莫司的简单且可靠的液相色谱-串联质谱法。
Bioanalysis. 2014;6(12):1597-604. doi: 10.4155/bio.14.43.
8
Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.超快速液相色谱-串联质谱法常规方法,使用氘代内标物(环孢素 A 和依维莫司)同时测定全血中环孢素 A、他克莫司、西罗莫司和依维莫司。
Ther Drug Monit. 2010 Feb;32(1):61-6. doi: 10.1097/FTD.0b013e3181c49a00.
9
Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS).采用高分辨质谱(HRMS)定量测定四种免疫抑制剂。
Clin Chem Lab Med. 2016 Jul 1;54(7):1193-200. doi: 10.1515/cclm-2015-0863.
10
Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.一种新的液相色谱/串联质谱法测定全血中依维莫司浓度的分析性能。
Ther Drug Monit. 2012 Apr;34(2):222-6. doi: 10.1097/FTD.0b013e318246d515.

引用本文的文献

1
Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies.液相色谱-串联质谱法(LC-MS/MS)与酶放大免疫测定技术(EMIT)用于精确测定血管异常患儿血液中西罗莫司的比较
Front Pharmacol. 2022 Sep 6;13:925018. doi: 10.3389/fphar.2022.925018. eCollection 2022.
2
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin).西罗莫司治疗β地中海贫血患者时γ珠蛋白基因的表达:一项试点临床试验(Sirthalaclin)的结果
Ther Adv Hematol. 2022 Jun 21;13:20406207221100648. doi: 10.1177/20406207221100648. eCollection 2022.